Efficacy and tolerability of two different formulations of atorvastatin in Korean patients with hypercholesterolemia: a multicenter, prospective, randomized clinical trial

@inproceedings{Lee2017EfficacyAT,
  title={Efficacy and tolerability of two different formulations of atorvastatin in Korean patients with hypercholesterolemia: a multicenter, prospective, randomized clinical trial},
  author={Ju Hee Lee and Sanghyun Kim and Dong Ju Choi and Seung Jea Tahk and Jung-han Yoon and Si Wan Choi and Taek-Jong Hong and Hyo Soo Kim},
  booktitle={Drug design, development and therapy},
  year={2017}
}
PURPOSE This study was designed to compare the efficacy and tolerability of the generic formulation (Atorva®) and the reference formulation (Lipitor®) of atorvastatin, both at a dosage of 20 mg once daily. METHODS This study was a prospective open-label, randomized controlled study. Hypercholesterolemic patients who had not achieved low-density… CONTINUE READING